Stent Trombozu ve Restenozunda Perkütan Koroner Girişim

Roger VL, Go AS, Lloyd-Jones, et al. Heart disease and stroke statistics--2011 update: A report from the American Heart Association. Circulation 2011; 125: 2-220.

Bashore TM, Bates ER, Berger P, et al. Clinical Expert Consensus Document on cardiac catheterization laboratory standards: a report of the American Collage of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001; 37: 2170-214.

Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. The New England journal of medicine. 2012;366:54-63

Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. The New England journal of medicine. 1987;316:701-706

Serruys PW, De Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-95.

Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines of percutaneous coronary interventions-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice. J Am Coll Cardiol 2001; 37: 2215-39.

Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005; 352: 2174-83.

Mercado N, Boersma E, Wijns W, et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 2001; 38: 645-52.

Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and 6-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005; 45: 947-53.

Kedhi E. Joesoef KS. Mcfadden E, et al. Second generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet 2010;375 (9710):201-9.

Cutlip DE, Windecker S, Mehran R, et al. Academic Research C. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation. 2007;115:2344-2351

Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation. 2001;103:1967-1971

Dangas G, Mehran R, Abizaid AS, et al. Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting. Am J Cardiol. 2001;87:470-472, A477

Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet. 2007;369:667-678

Honda Y, Fitzgerald PJ. Stent thrombosis: An issue revisited in a changing world. Circulation. 2003;108:2-5

Pfisterer M, Brunner-La Rocca HP, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48:2584-2591

Wenaweser P, Daemen J, Zwahlen M, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52:1134-1140

Lemesle G, Delhaye C, Bonello L, et al. Stent thrombosis in 2008: Definition, predictors, prognosis and treatment. Archives of cardiovascular diseases. 2008;101:769777

Baran KW, Lasala JM, Cox DA, et al. A clinical risk score for prediction of stent thrombosis. Am J Cardiol. 2008;102:541-545

D’ascenzo F. Bollati M. Clementi F, et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol 2013;167(2):575-84.

The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). ESC/ EACTS Guidelines on Myocardial Revascularisation. Eur Heart J 2014;35:2541-619.

Kipshidze N, Dangas G, Tsapenko M, et al. Role of the endothelium in modulating neointimal formation: Vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol. 2004;44:733739

Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. The Journal of pathology. 2000;190:300-309

Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996; 94: 1247-54.

Pugliese F, Cademartiri F, van Mieghem C, et al. Multidetector CT for visualization of coronary stents. Radiographics 2006; 26: 887-904.

Mahnken AH. CT imaging of coronary stents: Past, present, and future. ISRN Cardiology 2012; doi:10.5402/2012/139823.

Van der Hoeven BL, Pires NM, Warda HM, et al. Drug-eluting stents: results, promises and problems. Int J Cardiol 2005; 99: 9-17.

Narins CR, Ellis SG. Prevention of in-stent restenosis. Seminars in interventional cardiology: SIIC. 1998;3:91-103

29.Byrne RA, Joner M, Massberg S, et al. Restenosis in bare metal and drug-eluting stents. In Coronary stenosis, imaging, structure and physiology, 1st Edition; Escaned J, Serruys PW, Eds.; Europa Edition: Toulouse, France, 2010; 475–496.

Lowe HC, Oesterle SN, Khachigian LM, et al. Coronary in-stent restenosis: Current status and future strategies. J Am Coll Cardiol. 2002;39:183193

Moreno PR, Palacios IF, Leon MN, et al. Histopathologic comparison of human coronary in-stent and postballoon angioplasty restenotic tissue. Am J Cardiol. 1999;84:462-466, A469

Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study. Circulation. 1996;94:35-43

Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis classification and implications for long- term outcome. Circulation 1999; 100: 1872–1878.

34.Farooq V, Räber L, Gogas BD, et al. In-stent restenosis. In Percutaneous interventional cardiovascular medicine, the PCR-EAPCI textbook, 1st Edition; Eeckhout E, Serruys PW, Wijns W, et al, Eds.; Europa Edition: Toulouse, France, 2012; 785–826.

35.Bainey KR, Norris CM, Graham MM, et al. Clinical in-stent restenosis with bare metal stents: Is it truly a benign phenomenon? Int J Cardiol 2008; 128: 378–382.

36. Kim MS, Dean LS. In-stent restenosis. Cardiovasc Ther 2011; 29: 190–198.

37.Scott NA. Restenosis following implantation of bare metal coronary stents: Pathophysiology and pathways involved in the vascular response to injury. Adv Drug Deliv Rev 2006; 58: 358–376.

38. Giacoppo D, Alfonso F, Xu B, et al. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. J Am Coll Cardiol. 2020 Jun 2;75(21):2664-2678. doi: 10.1016/j.jacc.2020.04.006.